203 related articles for article (PubMed ID: 34511583)
1. The biology of the tumor microenvironment in DLBCL: Targeting the "don't eat me" signal.
Ennishi D
J Clin Exp Hematop; 2021 Dec; 61(4):210-215. PubMed ID: 34511583
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures.
Kotlov N; Bagaev A; Revuelta MV; Phillip JM; Cacciapuoti MT; Antysheva Z; Svekolkin V; Tikhonova E; Miheecheva N; Kuzkina N; Nos G; Tabbo F; Frenkel F; Ghione P; Tsiper M; Almog N; Fowler N; Melnick AM; Leonard JP; Inghirami G; Cerchietti L
Cancer Discov; 2021 Jun; 11(6):1468-1489. PubMed ID: 33541860
[TBL] [Abstract][Full Text] [Related]
3. CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL.
Bouwstra R; He Y; de Boer J; Kooistra H; Cendrowicz E; Fehrmann RSN; Ammatuna E; Zu Eulenburg C; Nijland M; Huls G; Bremer E; van Meerten T
Cancer Immunol Res; 2019 Oct; 7(10):1663-1671. PubMed ID: 31409608
[TBL] [Abstract][Full Text] [Related]
4. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Steen CB; Luca BA; Esfahani MS; Azizi A; Sworder BJ; Nabet BY; Kurtz DM; Liu CL; Khameneh F; Advani RH; Natkunam Y; Myklebust JH; Diehn M; Gentles AJ; Newman AM; Alizadeh AA
Cancer Cell; 2021 Oct; 39(10):1422-1437.e10. PubMed ID: 34597589
[TBL] [Abstract][Full Text] [Related]
5. Don't eat me/eat me signals as a novel strategy in cancer immunotherapy.
Khalaji A; Yancheshmeh FB; Farham F; Khorram A; Sheshbolouki S; Zokaei M; Vatankhah F; Soleymani-Goloujeh M
Heliyon; 2023 Oct; 9(10):e20507. PubMed ID: 37822610
[TBL] [Abstract][Full Text] [Related]
6. Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.
Kelley SM; Ravichandran KS
EMBO Rep; 2021 Jun; 22(6):e52564. PubMed ID: 34041845
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
[TBL] [Abstract][Full Text] [Related]
8. Efferocytosis and the Story of "Find Me," "Eat Me," and "Don't Eat Me" Signaling in the Tumor Microenvironment.
Banerjee HN; Bartlett V; Krauss C; Aurelius C; Johnston K; Hedley J; Verma M
Adv Exp Med Biol; 2021; 1329():153-162. PubMed ID: 34664238
[TBL] [Abstract][Full Text] [Related]
9. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.
Ennishi D; Healy S; Bashashati A; Saberi S; Hother C; Mottok A; Chan FC; Chong L; Abraham L; Kridel R; Boyle M; Meissner B; Aoki T; Takata K; Woolcock BW; Viganò E; Gold M; Molday LL; Molday RS; Telenius A; Li MY; Wretham N; Dos Santos N; Wong M; Viller NN; Uger RA; Duns G; Baticados A; Madero A; Bristow BN; Farinha P; Slack GW; Ben-Neriah S; Lai D; Zhang AW; Salehi S; Shulha HP; Chiu DS; Mostafavi S; Gerrie AS; Huang DW; Rushton C; Villa D; Sehn LH; Savage KJ; Mungall AJ; Weng AP; Bally MB; Morin RD; Cohen Freue GV; Staudt LM; Connors JM; Marra MA; Shah SP; Gascoyne RD; Scott DW; Steidl C
Nat Med; 2020 Apr; 26(4):577-588. PubMed ID: 32094924
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
11. Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibody.
Nakamura K; Casey M; Oey H; Vari F; Stagg J; Gandhi MK; Smyth MJ
Leukemia; 2020 Oct; 34(10):2708-2721. PubMed ID: 32269319
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
13. Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma.
Kazama R; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yoshida N; Kawamoto K; Yanagida E; Yamada K; Umeno T; Suzuki T; Kato K; Takizawa J; Seto M; Akashi K; Ohshima K
Cancer Sci; 2020 Jul; 111(7):2608-2619. PubMed ID: 32342603
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances in molecular pathophysiology in diffuse large B-cell lymphoma and high-grade B-cell lymphoma].
Ennishi D
Rinsho Ketsueki; 2021; 62(6):624-630. PubMed ID: 34219090
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.
Sangaletti S; Iannelli F; Zanardi F; Cancila V; Portararo P; Botti L; Vacca D; Chiodoni C; Di Napoli A; Valenti C; Rizzello C; Vegliante MC; Pisati F; Gulino A; Ponzoni M; Colombo MP; Tripodo C
EBioMedicine; 2020 Nov; 61():103055. PubMed ID: 33096480
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population.
Parkhi M; Chatterjee D; Bal A; Vias P; Yadav BS; Prakash G; Gupta SK; Radotra BD
APMIS; 2022 Feb; 130(2):82-94. PubMed ID: 34862664
[TBL] [Abstract][Full Text] [Related]
17. Biology of Tumor Associated Macrophages in Diffuse Large B Cell Lymphoma.
Huang W; Wei X; Wei Y; Feng R
DNA Cell Biol; 2018 Nov; ():. PubMed ID: 30403536
[TBL] [Abstract][Full Text] [Related]
18. Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B-cell lymphoma.
Cerchietti L
Blood; 2024 Mar; 143(12):1101-1111. PubMed ID: 38211334
[TBL] [Abstract][Full Text] [Related]
19. New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice.
Friedberg JW
Clin Cancer Res; 2011 Oct; 17(19):6112-7. PubMed ID: 21844008
[TBL] [Abstract][Full Text] [Related]
20. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy.
Foxall R; Narang P; Glaysher B; Hub E; Teal E; Coles MC; Ashton-Key M; Beers SA; Cragg MS
Front Immunol; 2020; 11():605231. PubMed ID: 33628205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
